19 results
8-K/A
EX-10.1
PTPI
Petros Pharmaceuticals Inc
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
action in writing or verbally which could reasonably be expected to adversely affect the Company’s reputation or the personal or professional … reputation of any of its owners, affiliates directors, officers, agents or employees or their operations, procedures, activities, services, policies
S-3
PTPI
Petros Pharmaceuticals Inc
29 Jan 21
Shelf registration
4:48pm
data in Petros’ nonclinical studies or clinical trials, which could result in regulatory sanctions and cause serious harm to Petros’ reputation … security breaches could compromise our proprietary and confidential information, which could harm our business and reputation.
In the ordinary course
424B5
PTPI
Petros Pharmaceuticals Inc
15 Oct 21
Prospectus supplement for primary offering
5:01pm
serious harm to Petros’ reputation.
Additionally, Petros is subject to the risk that a person could allege such fraud or other misconduct, even if none … and reputation.
In the ordinary course of our business, Petros generates, collects and stores proprietary information, including intellectual property
424B5
aaodpf7uyfhdcn54fjtw
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B5
dz3x3xfj15k6 w1
23 Dec 21
Prospectus supplement for primary offering
5:01pm
10-K
jcgkuj 9awx3lc
31 Mar 21
Annual report
4:30pm
424B3
6cfl19 82qadg
14 Jan 22
Prospectus supplement
5:18pm
S-4/A
9z84 3fhhp22uto
30 Sep 20
Registration of securities issued in business combination transactions (amended)
9:21am
S-4
4w9vn
24 Jul 20
Registration of securities issued in business combination transactions
12:00am
424B3
zbm78
2 Nov 20
Prospectus supplement
12:00am
- Prev
- 1
- Next